Position in RPRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,202,751
-$753,476 QoQ
Shares Held
25,073
-50.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 99.80855900769753.ToString("F0")%
Shared 0.ToString("F0")%
None 0.19144099230247677.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AlTi Global, Inc. holds $5,270,139 across 9 Biotechnology names. RPRX ranks #2 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,857 | $1,434,792 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
25,073 | $1,202,751 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,492 | $781,017 | |
| 4 | CELC |
Celcuity Inc.
|
5,287 | $603,458 | |
| 5 | MDXG |
Mimedx Group, Inc.
|
95,212 | $376,087 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
673 | $300,520 | |
| 7 | RLMD |
Relmada Therapeutics, Inc.
|
31,975 | $222,546 | |
| 8 | MRNA |
Moderna, Inc.
|
4,220 | $214,375 |
All Filings in RPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,202,751 | 25,073 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $1,956,227 | 50,627 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,483,782 | 70,402 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $3,240,754 | 89,946 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $5,100,214 | 163,836 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,886,834 | 387,567 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||